Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 23

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

554

HTML

4352

Tables (1-8)

224

Sum=5130

Jun 21, 2006 (publication date) through May 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jun 21, 2006; 12(23): 3682-3694
Published online Jun 21, 2006. doi: 10.3748/wjg.v12.i23.3682

Table 3 Features of the ideal marker of liver fibrosis

Specific for fibrosis of the liver

Providing measurement of: A) stage of fibrosis, B) fibrogenesis activity

Not influenced by comorbidities (e.g. renal, reticulo-endothelial)

Known half-life

Known excretion route

Sensitive

Reproducible

Citation: Sebastiani G, Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 2006; 12(23): 3682-3694
URL: https://www.wjgnet.com/1007-9327/full/v12/i23/3682.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i23.3682